1. Home
  2. RWAY vs RAPP Comparison

RWAY vs RAPP Comparison

Compare RWAY & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RWAY
  • RAPP
  • Stock Information
  • Founded
  • RWAY 2015
  • RAPP 2022
  • Country
  • RWAY United States
  • RAPP United States
  • Employees
  • RWAY N/A
  • RAPP N/A
  • Industry
  • RWAY
  • RAPP
  • Sector
  • RWAY
  • RAPP
  • Exchange
  • RWAY Nasdaq
  • RAPP Nasdaq
  • Market Cap
  • RWAY 410.4M
  • RAPP 439.4M
  • IPO Year
  • RWAY 2021
  • RAPP 2024
  • Fundamental
  • Price
  • RWAY $10.23
  • RAPP $26.19
  • Analyst Decision
  • RWAY Buy
  • RAPP Strong Buy
  • Analyst Count
  • RWAY 6
  • RAPP 4
  • Target Price
  • RWAY $11.00
  • RAPP $37.00
  • AVG Volume (30 Days)
  • RWAY 217.5K
  • RAPP 1.5M
  • Earning Date
  • RWAY 11-11-2025
  • RAPP 11-06-2025
  • Dividend Yield
  • RWAY 13.70%
  • RAPP N/A
  • EPS Growth
  • RWAY 153.06
  • RAPP N/A
  • EPS
  • RWAY 1.91
  • RAPP N/A
  • Revenue
  • RWAY $140,975,000.00
  • RAPP N/A
  • Revenue This Year
  • RWAY N/A
  • RAPP N/A
  • Revenue Next Year
  • RWAY N/A
  • RAPP N/A
  • P/E Ratio
  • RWAY $5.34
  • RAPP N/A
  • Revenue Growth
  • RWAY N/A
  • RAPP N/A
  • 52 Week Low
  • RWAY $8.35
  • RAPP $6.43
  • 52 Week High
  • RWAY $11.73
  • RAPP $42.27
  • Technical
  • Relative Strength Index (RSI)
  • RWAY 32.39
  • RAPP 56.31
  • Support Level
  • RWAY $10.60
  • RAPP N/A
  • Resistance Level
  • RWAY $10.92
  • RAPP $25.14
  • Average True Range (ATR)
  • RWAY 0.15
  • RAPP 3.08
  • MACD
  • RWAY -0.05
  • RAPP -0.14
  • Stochastic Oscillator
  • RWAY 7.38
  • RAPP 61.96

About RWAY Runway Growth Finance Corp.

Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and UK, Canada, Netherlands, with the majority of its portfolio invested in the United States.

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: